For the safety of our patients, all guests must schedule their visit in advance.
262 Danny Thomas Place Memphis, TN 38105
Affiliate Clinic Locations
Call: 1-888-226-4343 Fax: 901-595-4011 Email: email@example.com Online: Referral Form Physician / Patient Referral Office
Patient & Family Resources
My St. Jude Patient Portal
Find a Local Event
Create an Event for St. Jude
Become a Monthly Donor
Our world-class experts. Your child’s care team.
Explore Our Research
Exceptional science. Innovative cures.
Give to our mission.
Why support us?
Shekinah is a cheerful girl known for her playfulness. But during the early part of 2017, Shekinah suddenly stopped being so active and began to suffer from frequent headaches.
Read This Patient's Story
Read about research being presented at the 2017 American Society of Hematology (ASH) meeting in Atlanta.
We have the world's best survival rates for some of the most aggressive cancers.
Running, walking or biking — what you resolve to do for your health this year can help save the lives of kids with cancer and other life-threatening diseases.
What happens when you give the world’s brightest minds the resources to do something remarkable? Cures.
Create your own fundraiser and do what you love while helping the kids of St. Jude.
See why St. Jude tops the list in pediatric cancer specialty by U.S. News & World Report.
"To be able to just get my son here and not think about how we will pay for it, it just takes so much weight off of my family," says Bryce's mom.
DXL Names Microscopy Center
We share our research with the world, leading a global effort to understand, treat, and defeat pediatric cancer and other life-threatening diseases.
Mutz will play a key role in the
St. Jude Strategic Plan and future hospital expansion.
Quality improvement effort shows the way to enhance vaccination among health care providers and protect patients.
St. Jude researchers pinpoint the cell type that turns malignant in rhabdomyosarcoma, which could open the path for better treatments.
Read about the TP53 gene variations that leave young people more likely to develop acute lymphoblastic leukemia and to die as a result.
The scientists showed that certain memory T cells develop from T cells originally made by the body for another role.
Early results suggest gene therapy is well tolerated and effective for babies with X-linked severe combined immunodeficiency disorder, or "bubble boy" disease.
More Science & Medicine